ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurodegenerative Disease Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-37Z1691
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Neurodegenerative Disease Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Neurodegenerative Disease Market Research Report 2025

Code: QYRE-Auto-37Z1691
Report
September 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Pfizer Inc
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline PLC
Livzon Pharmaceutical
Haisco Pharmaceutical
JINGXIN PHARMACEUTICAL
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS

Neurodegenerative Disease Market Size

The global market for Neurodegenerative Disease was valued at US$ 7443 million in the year 2024 and is projected to reach a revised size of US$ 9199 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Neurodegenerative Disease Market

Neurodegenerative Disease Market

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer"s disease, Parkinson"s disease, and amyotrophic lateral sclerosis (ALS).
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market"s growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease.
The Neurodegenerative Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurodegenerative Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurodegenerative Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurodegenerative Disease Market Report

Report Metric Details
Report Name Neurodegenerative Disease Market
Accounted market size in year US$ 7443 million
Forecasted market size in 2031 US$ 9199 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Parkinson’s Disease
  • Huntington Disease
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s Disease
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline, Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals, Hisun Pharmaceutical, Luye Pharma, Ark Pharmaceutical, Kanghong Pharmaceutical, Huahai Pharmaceutical, BORA PHARMACEUTICALS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurodegenerative Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neurodegenerative Disease Market growing?

Ans: The Neurodegenerative Disease Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Neurodegenerative Disease Market size in 2031?

Ans: The Neurodegenerative Disease Market size in 2031 will be US$ 9199 million.

Who are the main players in the Neurodegenerative Disease Market report?

Ans: The main players in the Neurodegenerative Disease Market are Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline, Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals, Hisun Pharmaceutical, Luye Pharma, Ark Pharmaceutical, Kanghong Pharmaceutical, Huahai Pharmaceutical, BORA PHARMACEUTICALS

What are the Application segmentation covered in the Neurodegenerative Disease Market report?

Ans: The Applications covered in the Neurodegenerative Disease Market report are Parkinson’s Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease

What are the Type segmentation covered in the Neurodegenerative Disease Market report?

Ans: The Types covered in the Neurodegenerative Disease Market report are NMDA, SSRIs, Dopamine Inhibitors

Recommended Reports

Neurodegenerative Diseases

Neuromuscular Disorders

Neurotechnology Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Parkinson’s Disease
1.3.3 Huntington Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Alzheimer’s Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Market Perspective (2020-2031)
2.2 Global Neurodegenerative Disease Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurodegenerative Disease Historic Market Size by Region (2020-2025)
2.2.3 Neurodegenerative Disease Forecasted Market Size by Region (2026-2031)
2.3 Neurodegenerative Disease Market Dynamics
2.3.1 Neurodegenerative Disease Industry Trends
2.3.2 Neurodegenerative Disease Market Drivers
2.3.3 Neurodegenerative Disease Market Challenges
2.3.4 Neurodegenerative Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Players by Revenue (2020-2025)
3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2020-2025)
3.2 Global Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurodegenerative Disease Revenue
3.4 Global Neurodegenerative Disease Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Revenue in 2024
3.5 Global Key Players of Neurodegenerative Disease Head office and Area Served
3.6 Global Key Players of Neurodegenerative Disease, Product and Application
3.7 Global Key Players of Neurodegenerative Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Breakdown Data by Type
4.1 Global Neurodegenerative Disease Historic Market Size by Type (2020-2025)
4.2 Global Neurodegenerative Disease Forecasted Market Size by Type (2026-2031)
5 Neurodegenerative Disease Breakdown Data by Application
5.1 Global Neurodegenerative Disease Historic Market Size by Application (2020-2025)
5.2 Global Neurodegenerative Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurodegenerative Disease Market Size (2020-2031)
6.2 North America Neurodegenerative Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurodegenerative Disease Market Size by Country (2020-2025)
6.4 North America Neurodegenerative Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Market Size (2020-2031)
7.2 Europe Neurodegenerative Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurodegenerative Disease Market Size by Country (2020-2025)
7.4 Europe Neurodegenerative Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Market Size (2020-2031)
8.2 Asia-Pacific Neurodegenerative Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurodegenerative Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurodegenerative Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Market Size (2020-2031)
9.2 Latin America Neurodegenerative Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurodegenerative Disease Market Size by Country (2020-2025)
9.4 Latin America Neurodegenerative Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Market Size (2020-2031)
10.2 Middle East & Africa Neurodegenerative Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurodegenerative Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurodegenerative Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Neurodegenerative Disease Introduction
11.1.4 Novartis Revenue in Neurodegenerative Disease Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Neurodegenerative Disease Introduction
11.2.4 Pfizer Revenue in Neurodegenerative Disease Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Merck Serono
11.3.1 Merck Serono Company Details
11.3.2 Merck Serono Business Overview
11.3.3 Merck Serono Neurodegenerative Disease Introduction
11.3.4 Merck Serono Revenue in Neurodegenerative Disease Business (2020-2025)
11.3.5 Merck Serono Recent Development
11.4 Biogen Idec
11.4.1 Biogen Idec Company Details
11.4.2 Biogen Idec Business Overview
11.4.3 Biogen Idec Neurodegenerative Disease Introduction
11.4.4 Biogen Idec Revenue in Neurodegenerative Disease Business (2020-2025)
11.4.5 Biogen Idec Recent Development
11.5 TEVA
11.5.1 TEVA Company Details
11.5.2 TEVA Business Overview
11.5.3 TEVA Neurodegenerative Disease Introduction
11.5.4 TEVA Revenue in Neurodegenerative Disease Business (2020-2025)
11.5.5 TEVA Recent Development
11.6 UCB
11.6.1 UCB Company Details
11.6.2 UCB Business Overview
11.6.3 UCB Neurodegenerative Disease Introduction
11.6.4 UCB Revenue in Neurodegenerative Disease Business (2020-2025)
11.6.5 UCB Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Neurodegenerative Disease Introduction
11.7.4 Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2020-2025)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Neurodegenerative Disease Introduction
11.8.4 Sanofi Revenue in Neurodegenerative Disease Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Neurodegenerative Disease Introduction
11.9.4 GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Details
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Introduction
11.10.4 Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.10.5 Livzon Pharmaceutical Recent Development
11.11 Haisco Pharmaceutical
11.11.1 Haisco Pharmaceutical Company Details
11.11.2 Haisco Pharmaceutical Business Overview
11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Introduction
11.11.4 Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.11.5 Haisco Pharmaceutical Recent Development
11.12 Jingxin Pharmaceutical
11.12.1 Jingxin Pharmaceutical Company Details
11.12.2 Jingxin Pharmaceutical Business Overview
11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Introduction
11.12.4 Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.12.5 Jingxin Pharmaceutical Recent Development
11.13 Dongcheng Biochemicals
11.13.1 Dongcheng Biochemicals Company Details
11.13.2 Dongcheng Biochemicals Business Overview
11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Introduction
11.13.4 Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2020-2025)
11.13.5 Dongcheng Biochemicals Recent Development
11.14 Hisun Pharmaceutical
11.14.1 Hisun Pharmaceutical Company Details
11.14.2 Hisun Pharmaceutical Business Overview
11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Introduction
11.14.4 Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.14.5 Hisun Pharmaceutical Recent Development
11.15 Luye Pharma
11.15.1 Luye Pharma Company Details
11.15.2 Luye Pharma Business Overview
11.15.3 Luye Pharma Neurodegenerative Disease Introduction
11.15.4 Luye Pharma Revenue in Neurodegenerative Disease Business (2020-2025)
11.15.5 Luye Pharma Recent Development
11.16 Ark Pharmaceutical
11.16.1 Ark Pharmaceutical Company Details
11.16.2 Ark Pharmaceutical Business Overview
11.16.3 Ark Pharmaceutical Neurodegenerative Disease Introduction
11.16.4 Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.16.5 Ark Pharmaceutical Recent Development
11.17 Kanghong Pharmaceutical
11.17.1 Kanghong Pharmaceutical Company Details
11.17.2 Kanghong Pharmaceutical Business Overview
11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Introduction
11.17.4 Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.17.5 Kanghong Pharmaceutical Recent Development
11.18 Huahai Pharmaceutical
11.18.1 Huahai Pharmaceutical Company Details
11.18.2 Huahai Pharmaceutical Business Overview
11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Introduction
11.18.4 Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025)
11.18.5 Huahai Pharmaceutical Recent Development
11.19 BORA PHARMACEUTICALS
11.19.1 BORA PHARMACEUTICALS Company Details
11.19.2 BORA PHARMACEUTICALS Business Overview
11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Introduction
11.19.4 BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2020-2025)
11.19.5 BORA PHARMACEUTICALS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Pfizer Inc
Merck Serono
Biogen Idec
TEVA
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline PLC
Livzon Pharmaceutical
Haisco Pharmaceutical
JINGXIN PHARMACEUTICAL
Dongcheng Biochemicals
Hisun Pharmaceutical
Luye Pharma
Ark Pharmaceutical
Kanghong Pharmaceutical
Huahai Pharmaceutical
BORA PHARMACEUTICALS
List of Tables
 Table 1. Global Neurodegenerative Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NMDA
 Table 3. Key Players of SSRIs
 Table 4. Key Players of Dopamine Inhibitors
 Table 5. Global Neurodegenerative Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Neurodegenerative Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Neurodegenerative Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Neurodegenerative Disease Market Share by Region (2020-2025)
 Table 9. Global Neurodegenerative Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Neurodegenerative Disease Market Share by Region (2026-2031)
 Table 11. Neurodegenerative Disease Market Trends
 Table 12. Neurodegenerative Disease Market Drivers
 Table 13. Neurodegenerative Disease Market Challenges
 Table 14. Neurodegenerative Disease Market Restraints
 Table 15. Global Neurodegenerative Disease Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Neurodegenerative Disease Market Share by Players (2020-2025)
 Table 17. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2024)
 Table 18. Ranking of Global Top Neurodegenerative Disease Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Neurodegenerative Disease Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Neurodegenerative Disease, Headquarters and Area Served
 Table 21. Global Key Players of Neurodegenerative Disease, Product and Application
 Table 22. Global Key Players of Neurodegenerative Disease, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Neurodegenerative Disease Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Neurodegenerative Disease Revenue Market Share by Type (2020-2025)
 Table 26. Global Neurodegenerative Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Neurodegenerative Disease Revenue Market Share by Type (2026-2031)
 Table 28. Global Neurodegenerative Disease Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Neurodegenerative Disease Revenue Market Share by Application (2020-2025)
 Table 30. Global Neurodegenerative Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Neurodegenerative Disease Revenue Market Share by Application (2026-2031)
 Table 32. North America Neurodegenerative Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Neurodegenerative Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Neurodegenerative Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Neurodegenerative Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Neurodegenerative Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Neurodegenerative Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Neurodegenerative Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Neurodegenerative Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Neurodegenerative Disease Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Neurodegenerative Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Neurodegenerative Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Neurodegenerative Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Neurodegenerative Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Neurodegenerative Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Neurodegenerative Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Novartis Company Details
 Table 48. Novartis Business Overview
 Table 49. Novartis Neurodegenerative Disease Product
 Table 50. Novartis Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 51. Novartis Recent Development
 Table 52. Pfizer Company Details
 Table 53. Pfizer Business Overview
 Table 54. Pfizer Neurodegenerative Disease Product
 Table 55. Pfizer Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 56. Pfizer Recent Development
 Table 57. Merck Serono Company Details
 Table 58. Merck Serono Business Overview
 Table 59. Merck Serono Neurodegenerative Disease Product
 Table 60. Merck Serono Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 61. Merck Serono Recent Development
 Table 62. Biogen Idec Company Details
 Table 63. Biogen Idec Business Overview
 Table 64. Biogen Idec Neurodegenerative Disease Product
 Table 65. Biogen Idec Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 66. Biogen Idec Recent Development
 Table 67. TEVA Company Details
 Table 68. TEVA Business Overview
 Table 69. TEVA Neurodegenerative Disease Product
 Table 70. TEVA Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 71. TEVA Recent Development
 Table 72. UCB Company Details
 Table 73. UCB Business Overview
 Table 74. UCB Neurodegenerative Disease Product
 Table 75. UCB Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 76. UCB Recent Development
 Table 77. Boehringer Ingelheim Company Details
 Table 78. Boehringer Ingelheim Business Overview
 Table 79. Boehringer Ingelheim Neurodegenerative Disease Product
 Table 80. Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 81. Boehringer Ingelheim Recent Development
 Table 82. Sanofi Company Details
 Table 83. Sanofi Business Overview
 Table 84. Sanofi Neurodegenerative Disease Product
 Table 85. Sanofi Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 86. Sanofi Recent Development
 Table 87. GlaxoSmithKline Company Details
 Table 88. GlaxoSmithKline Business Overview
 Table 89. GlaxoSmithKline Neurodegenerative Disease Product
 Table 90. GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 91. GlaxoSmithKline Recent Development
 Table 92. Livzon Pharmaceutical Company Details
 Table 93. Livzon Pharmaceutical Business Overview
 Table 94. Livzon Pharmaceutical Neurodegenerative Disease Product
 Table 95. Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 96. Livzon Pharmaceutical Recent Development
 Table 97. Haisco Pharmaceutical Company Details
 Table 98. Haisco Pharmaceutical Business Overview
 Table 99. Haisco Pharmaceutical Neurodegenerative Disease Product
 Table 100. Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 101. Haisco Pharmaceutical Recent Development
 Table 102. Jingxin Pharmaceutical Company Details
 Table 103. Jingxin Pharmaceutical Business Overview
 Table 104. Jingxin Pharmaceutical Neurodegenerative Disease Product
 Table 105. Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 106. Jingxin Pharmaceutical Recent Development
 Table 107. Dongcheng Biochemicals Company Details
 Table 108. Dongcheng Biochemicals Business Overview
 Table 109. Dongcheng Biochemicals Neurodegenerative Disease Product
 Table 110. Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 111. Dongcheng Biochemicals Recent Development
 Table 112. Hisun Pharmaceutical Company Details
 Table 113. Hisun Pharmaceutical Business Overview
 Table 114. Hisun Pharmaceutical Neurodegenerative Disease Product
 Table 115. Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 116. Hisun Pharmaceutical Recent Development
 Table 117. Luye Pharma Company Details
 Table 118. Luye Pharma Business Overview
 Table 119. Luye Pharma Neurodegenerative Disease Product
 Table 120. Luye Pharma Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 121. Luye Pharma Recent Development
 Table 122. Ark Pharmaceutical Company Details
 Table 123. Ark Pharmaceutical Business Overview
 Table 124. Ark Pharmaceutical Neurodegenerative Disease Product
 Table 125. Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 126. Ark Pharmaceutical Recent Development
 Table 127. Kanghong Pharmaceutical Company Details
 Table 128. Kanghong Pharmaceutical Business Overview
 Table 129. Kanghong Pharmaceutical Neurodegenerative Disease Product
 Table 130. Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 131. Kanghong Pharmaceutical Recent Development
 Table 132. Huahai Pharmaceutical Company Details
 Table 133. Huahai Pharmaceutical Business Overview
 Table 134. Huahai Pharmaceutical Neurodegenerative Disease Product
 Table 135. Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 136. Huahai Pharmaceutical Recent Development
 Table 137. BORA PHARMACEUTICALS Company Details
 Table 138. BORA PHARMACEUTICALS Business Overview
 Table 139. BORA PHARMACEUTICALS Neurodegenerative Disease Product
 Table 140. BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2020-2025) & (US$ Million)
 Table 141. BORA PHARMACEUTICALS Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Neurodegenerative Disease Picture
 Figure 2. Global Neurodegenerative Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurodegenerative Disease Market Share by Type: 2024 VS 2031
 Figure 4. NMDA Features
 Figure 5. SSRIs Features
 Figure 6. Dopamine Inhibitors Features
 Figure 7. Global Neurodegenerative Disease Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Neurodegenerative Disease Market Share by Application: 2024 VS 2031
 Figure 9. Parkinson’s Disease Case Studies
 Figure 10. Huntington Disease Case Studies
 Figure 11. Amyotrophic Lateral Sclerosis Case Studies
 Figure 12. Alzheimer’s Disease Case Studies
 Figure 13. Neurodegenerative Disease Report Years Considered
 Figure 14. Global Neurodegenerative Disease Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Neurodegenerative Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Neurodegenerative Disease Market Share by Region: 2024 VS 2031
 Figure 17. Global Neurodegenerative Disease Market Share by Players in 2024
 Figure 18. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Revenue in 2024
 Figure 20. North America Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Neurodegenerative Disease Market Share by Country (2020-2031)
 Figure 22. United States Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Neurodegenerative Disease Market Share by Country (2020-2031)
 Figure 26. Germany Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Neurodegenerative Disease Market Share by Region (2020-2031)
 Figure 34. China Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Neurodegenerative Disease Market Share by Country (2020-2031)
 Figure 42. Mexico Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Neurodegenerative Disease Market Share by Country (2020-2031)
 Figure 46. Turkey Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Neurodegenerative Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Novartis Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 51. Merck Serono Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 52. Biogen Idec Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 53. TEVA Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 54. UCB Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 55. Boehringer Ingelheim Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 57. GlaxoSmithKline Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 58. Livzon Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 59. Haisco Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 60. Jingxin Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 61. Dongcheng Biochemicals Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 62. Hisun Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 63. Luye Pharma Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 64. Ark Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 65. Kanghong Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 66. Huahai Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 67. BORA PHARMACEUTICALS Revenue Growth Rate in Neurodegenerative Disease Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Neurodegenerative Disease Treatment Market Research Report 2024
Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030
Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disorder Therapeutics Market Research Report 2024
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Alzheimer s Disease Drug Market Insights Forecast to 2030
Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Global Neurometabolic Disorders Market Insights Forecast to 2030
Global Parkinson s Disease Treatment Market Insights Forecast to 2030
Global Targeted Drugs for Neurodegenerative Diseases Market Research Report 2024
Neurodegenerative Disease Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neurodegenerative Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Global Alzheimer s Disease Treatments Market Research Report 2024
Global Alzheimer Treatment Drug Market Research Report 2025
Global Parkinson s Disease Therapeutics Market Research Report 2025
Global Degenerative Disc Disease Treatment Market Research Report 2024

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions